Arecor Therapeutics PLC (DUS:6UI) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Andrew Richards | Non-Executive Chair and Chair of the Nomination Committee · Since at least Apr 13, 2026 |
| Arecor Therapeutics | Singer Capital Markets Advisory LLP · Since at least Jan 6, 2026 |
| David Ellam | Chief Financial Officer and Executive Director · Since at least Oct 15, 2026 |
| David Gerring | Chief Development Officer · Since at least May 21, 2026 |
| Jan Jezek | Chief Scientific Officer · Since at least Oct 15, 2026 |
| Jeremy Morgan | Non-Executive Director and Chair of the Remuneration Committee · Since at least Jun 2, 2025 |
| Phil Davies | Singer Capital Markets Advisory LLP · Since at least Apr 28, 2026 |
| Sam Fazeli | Non-Executive Director · Since at least Jun 2, 2025 |
| Sarah Howell | Chief Executive Officer and Executive Director · Since at least Oct 15, 2026 |
| Simon Ormiston | Non-Executive Director and Chair of the Audit & Risk Committee · Since at least Sep 29, 2025 |